Infectious Enteritis Treatment Market to reach $1,051.4 million by 2035
Infectious enteritis treatment market was valued at approximately $529.2 million in 2025 and is expected to reach around $1,051.4 million by 2035, registering a CAGR of 7.2% during the forecast period from 2026 to 2035. According to the World Health Organization (WHO), diarrhoeal disease remains a major global health challenge, with nearly 1.7?billion cases annually, often caused by intestinal infections that require clinical management. The disease burden, driven by pathogens such as E.?coli, Salmonella, and rotavirus, is a key factor fueling the growth of the Infectious Enteritis Treatment Market. The rising incidence of enteric infections, especially in pediatric populations and developing countries, is increasing demand for effective therapies. Common treatments include oral rehydration solutions (ORS), antibiotics, antivirals, probiotics, and supportive care. This high prevalence of infectious enteritis is driving the adoption of these therapies and shaping market expansion. The growing focus on pediatric care and emerging economies further reinforces the market’s growth trajectory.
Browse the full report description of “Infectious Enteritis Treatment Market Size, Share & Trends Analysis Report by Treatment (Antibiotics, Antivirals, Antiparasitic Drugs, Oral Rehydration Therapy (ORT), Antidiarrheal Agents, Probiotics), by Infection (Bacterial Enteritis, Viral Enteritis, Parasitic Enteritis), by Route of Administration (Oral, Intravenous (IV)), and Forecast Period (2026–2035)” at https://www.omrglobal.com/industry-reports/infectious-enteritis-treatment-market
Innovation Leaders Transforming the Infectious Enteritis Treatment Market
The key players in the infectious enteritis treatment market include top companies such as Johnson & Johnson, Merck & Co., Inc., Pfizer Inc., Bayer AG, and Sanofi S.A., among others. The market is driven by the rising incidence of infectious gastrointestinal diseases and increasing access to essential medicines globally. Growth is further supported by expanding OTC product penetration, such as probiotics and oral rehydration therapy (ORT). Pharmaceutical manufacturers are focusing on cost-effective generics and pediatric formulations to address high-burden regions. Additionally, improving healthcare infrastructure in emerging economies is strengthening treatment accessibility.
Recent developments include:
- In October 2024, Merck & Co. announced the presentation of more than 40 studies at IDWeek 2024, indicates progress in its vaccines and infectious disease pipeline.
Market Coverage
- The market number available for – 2025-2035
- Base year- 2025
- Forecast period- 2026-2035
- Segment Covered-
- By Treatment
- By Infection
- By Route of Administration
- Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Competitive Landscape: Johnson & Johnson, Merck & Co., Inc., Pfizer Inc., Bayer AG, and Sanofi S.A., among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- Who is the leader in the market?
- How are players addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Infectious Enteritis Treatment Market Report Segment
By Treatment
- Antibiotics
- Antivirals
- Antiparasitic Drugs
- Oral Rehydration Therapy (ORT)
- Antidiarrheal Agents
- Probiotics
By Infection
- Bacterial Enteritis
- Viral Enteritis
- Parasitic Enteritis
By Route of Administration
- Oral
- Intravenous (IV)
Global Infectious Enteritis Treatment Market Report Segment by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
Asia-Pacific
- China
- India
- Japan
- South Korea
- Australia and New Zealand
- ASEAN Economies
- Rest of Asia-Pacific
Rest of the World
- Latin America
- Middle East & Africa
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/infectious-enteritis-treatment-market